On-Demand Cell Line Development Webinars
-
Unlocking The Potential Of Electroporation
11/22/2024
Electroporation enables genetic research by introducing material into cells, advancing disease modeling, gene therapy, and ion channel studies.
-
Overcome The Limitations Of Conventional Transfection With Electroporation
11/22/2024
Learn how electroporation technology improves gene editing efficiency, reduces cell death, and enables scalable workflows for cell therapy, screening, and bioproduction in this informative webinar.
-
Manufacturing Strategies And Facility Design For Patient-Centric Delivery
11/21/2024
Review how to select the optimal manufacturing strategy and leverage technologies for efficient and scalable production of therapeutic proteins. De-risk the supply chain, accelerate time to market, and reduce costs.
-
Innovative Technologies To Accelerate Identification Of High-Quality Clones
11/18/2024
Cell line development (CLD) is a process often filled with obstacles that can significantly hinder scientific progress. Watch and learn how to overcome common challenges.
-
The Role Of Peptones In Boosting Quality And Yield
11/4/2024
Peptones can significantly boost CHO cell bioprocessing. We analyze their impact on diverse CHO cell lines using real-world data to assess their effects on titer, protein quality, and cell growth.
-
Scalable Production Of Lentivirus For Research To Commercial Manufacturing
10/30/2024
Join our webinar on scaling the CTS LV-MAX System in bioreactors, covering transfection scalability, Thermo S.U.B. advantages, and DynaSpin’s efficient gene therapy integration.
-
The Impact Of Pipetting Technique On Cell Line Development Workflows
10/29/2024
Explore the importance of analyzing key liquid handling parameters when optimizing assays, the effects of liquid handling variability in assays, methods to detect variability, and pipetting best practices.
-
Breaking Barriers: Combining Cell Line Development Innovation With Improved Process Development Workflows To Streamline Path To FIH
10/16/2024
Explore how KBI Biopharma’s SUREtechnology Platform™, powered by Selexis®, accelerates the development of complex biologics from early stages to first-in-human (FIH) trials, focusing on both speed and quality.
-
A Novel Transfection System For Cell And Gene Therapy Applications
10/3/2024
An innovative transfection system addresses common production challenges by offering higher AAV titers, improved percent-full AAV capsids, and a straightforward workflow for AAV production platforms.
-
Mastering The Art Of Developing A Successful Bispecific Antibody
10/3/2024
Learn innovative strategies to overcome the complexities of bispecific antibody development, from intelligent design to efficient purification techniques.